Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "MOMENTUM"

370 News Found

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat
Public Health | April 14, 2026

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape


Merck India, MAHE launch catalyst program to build future R&D talent pipeline
R&D | April 13, 2026

Merck India, MAHE launch catalyst program to build future R&D talent pipeline

MoU aims to strengthen academia-industry collaboration in healthcare research and innovation


Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care
Hospitals | April 13, 2026

Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care

Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems


Haemonetics gains FDA nod to expand VASCADE MVP XL for larger sheaths in heart procedures
Technology | April 12, 2026

Haemonetics gains FDA nod to expand VASCADE MVP XL for larger sheaths in heart procedures

The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths


Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
Digitisation | April 10, 2026

Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses

The device aims to bring precision neuroscience into clinical trials, accelerating drug development


Lupin scores major US breakthrough with FDA nod for key diabetes drug
Drug Approval | April 10, 2026

Lupin scores major US breakthrough with FDA nod for key diabetes drug

The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets


Dabur reports steady domestic growth amid global headwinds in Q4 FY26
News | April 08, 2026

Dabur reports steady domestic growth amid global headwinds in Q4 FY26

The India FMCG business showed a sequential recovery and is expected to post high-single digit growth


Alembic Pharma wins USFDA nod for generic Dapagliflozin, secures 180-day exclusivity
Drug Approval | April 07, 2026

Alembic Pharma wins USFDA nod for generic Dapagliflozin, secures 180-day exclusivity

Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.


Practo reports surge in  lifestyle disease awareness within Tier 2 cities, led by metabolic health searches
Healthcare | April 07, 2026

Practo reports surge in lifestyle disease awareness within Tier 2 cities, led by metabolic health searches

Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations